Cargando…
Identification and validation of a gene-based signature reveals SLC25A10 as a novel prognostic indicator for patients with ovarian cancer
BACKGROUND: Ovarian cancer is a common gynecological cancer with poor prognosis and poses a serious threat to woman life and health. In this study, we aimed to establish a prognostic signature for the risk assessment of ovarian cancer. METHODS: The Cancer Genome Atlas (TCGA) dataset was used as the...
Autores principales: | Li, Qi-jia, Wang, Juan, Jiang, Jing, Lin, Bing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482156/ https://www.ncbi.nlm.nih.gov/pubmed/36114504 http://dx.doi.org/10.1186/s13048-022-01039-4 |
Ejemplares similares
-
SLC25A1-associated prognostic signature predicts poor survival in acute myeloid leukemia patients
por: Liu, Fangshu, et al.
Publicado: (2023) -
Identification of a Prognostic Signature for Ovarian Cancer Based on the Microenvironment Genes
por: Huo, Xiao, et al.
Publicado: (2021) -
Identification and Validation of a Novel Prognostic Signature Based on Ferroptosis-Related Genes in Ovarian Cancer
por: Cheng, Zhe, et al.
Publicado: (2023) -
Identification of a Six-Gene SLC Family Signature With Prognostic Value in Patients With Lung Adenocarcinoma
por: Zhu, Jing, et al.
Publicado: (2021) -
SLC25A11 serves as a novel prognostic biomarker in liver cancer
por: Pan, Guoqiang, et al.
Publicado: (2020)